INDIA GLYCOLS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 833 INR | -0.89% |
|
+0.20% | +8.63% |
| Sales 2022 | 28.68B 344M | Sales 2023 | 26.51B 318M | Capitalization | 19.01B 228M |
|---|---|---|---|---|---|
| Net income 2022 | 3.4B 40.74M | Net income 2023 | 1.25B 14.99M | EV / Sales 2022 | 1.46 x |
| Net Debt 2022 | 10.4B 125M | Net Debt 2023 | 11.1B 133M | EV / Sales 2023 | 1.14 x |
| P/E ratio 2022 |
9.22
x | P/E ratio 2023 |
15.2
x | Employees | 1,284 |
| Yield 2022 |
0.74% | Yield 2023 |
1.22% | Free-Float | 33.13% |
More Fundamentals
* Assessed data
More news
Latest transcript on India Glycols Limited
More press releases
More news
| 1 day | -0.89% | ||
| 1 week | +0.20% | ||
| Current month | +10.07% | ||
| 1 month | +10.07% | ||
| 3 months | -5.74% | ||
| 6 months | +21.87% | ||
| Current year | +8.63% |
1 week
830.10
858.00
1 month
767.45882.75
Current year
750.00978.90
1 year
540.25978.90
3 years
463.001 153.10
5 years
176.151 153.10
10 years
65.251 153.10
| Managers | Title | Age | Since |
|---|---|---|---|
Rupark Sarswat
CEO | Chief Executive Officer | 52 | 21/20/21 |
Anand Singhal
DFI | Director of Finance/CFO | 57 | 02/08/02 |
| Chairman | 70 | 29/96/29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 68 | 26/09/26 | |
| Director/Board Member | 83 | 29/96/29 | |
Jayshree Bhartia
BRD | Director/Board Member | 66 | 28/99/28 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/24/29 | 833 | -0.89% | 3 965 |
| 26/24/26 | 840.4 | -1.43% | 4,301 |
| 25/24/25 | 852.6 | +0.58% | 1,754 |
| 24/24/24 | 847.8 | +1.71% | 2,881 |
| 23/24/23 | 833.5 | -0.82% | 1,143 |
Delayed Quote Bombay S.E., April 29, 2024 at 03:30 pm IST
More quotes
India Glycols Limited is an India-based company, which is engaged in manufacturing green technology-based bulk, specialty and performance chemicals and natural gums, spirits, industrial gases, sugar and nutraceuticals. The Company's segments include Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma. The Bio-based Specialities and Performance Chemicals segment comprises glycols, specialty chemicals, natural gum and other related goods. The Potable Spirits segment is engaged in the manufacturing and sale of ethyl alcohol (potable). The Ennature Biopharma segment is engaged in the manufacturing and sale of nutraceutical products. It has a product range that covers a variety of specialties and herbal products, such as nutraceuticals, phytochemicals, biopolymers, mainly Polygalactomannans, industrial gases and liquor. It serves various industries, such as automotive, detergents, healthcare and food processing, mining, and oil and gas, among others.
Sector
Commodity Chemicals
Calendar
22/05/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +8.63% | 312M | |
| +4.70% | 103B | |
| +2.40% | 65.6B | |
| +42.86% | 39.06B | |
| +16.96% | 37.58B | |
| +6.96% | 33.26B | |
| +7.89% | 19.22B | |
| +12.12% | 16.83B | |
| +12.08% | 15.03B | |
| +17.69% | 14.96B |
- Stock Market
- Equities
- INDIAGLYCO Stock
